Die Experten der Jefferies & Company Inc. bewerten in ihrer Analyse vom 27.10.25 die Aktie von Roche mit Underperform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback